Literature DB >> 10970156

Cyclosporin: nephro-protective as well as nephrotoxic?

P W Mathieson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970156      PMCID: PMC1905685          DOI: 10.1046/j.1365-2249.2000.01289.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  14 in total

1.  Cyclosporin A reduces expression of adhesion molecules in the kidney of rats with chronic serum sickness.

Authors:  J Rincón; G Parra; Y Quiroz; L Benatuil; B Rodríguez-Iturbe
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.

Authors:  T R Brazelton; R E Morris
Journal:  Curr Opin Immunol       Date:  1996-10       Impact factor: 7.486

Review 3.  Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.

Authors:  A M de Mattos; A J Olyaei; W M Bennett
Journal:  Am J Kidney Dis       Date:  2000-02       Impact factor: 8.860

4.  Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells.

Authors:  A Khanna; V Cairns; J D Hosenpud
Journal:  Transplantation       Date:  1999-02-27       Impact factor: 4.939

5.  Improved graft survival after renal transplantation in the United States, 1988 to 1996.

Authors:  S Hariharan; C P Johnson; B A Bresnahan; S E Taranto; M J McIntosh; D Stablein
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

6.  Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow.

Authors:  J M Vieira; I L Noronha; D M Malheiros; E A Burdmann
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

7.  Pharmacological immunosuppression in clinical organ grafting. Observations on four agents: cyclosporin A, Asta 5122 (cytimun), lambda carrageenan and promethazine hydrochloride.

Authors:  R Y Calne
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

8.  Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation.

Authors:  N A Clipstone; G R Crabtree
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

9.  The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients--a randomised prospective study.

Authors:  S J Harper; J Moorhouse; K Abrams; A Jurewicz; M Nicholson; T Horsburgh; K Harris; C Combe; P R Bell; J Walls; P K Donnelly; P S Veitch; J Feehally
Journal:  Transpl Int       Date:  1996       Impact factor: 3.782

10.  Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction.

Authors:  B Li; P K Sehajpal; A Khanna; H Vlassara; A Cerami; K H Stenzel; M Suthanthiran
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  2 in total

1.  Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.

Authors:  S D Lytton; U Berg; A Nemeth; M Ingelman-Sundberg
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  Micophenolat Mofetil versus Azathioprine: effects on renal graft function in early posttransplant period.

Authors:  Farid Ljuca; Semir Imamović; Deso Mesić; Sefik Hasukić Hasukić; Safet Omerović; Mustafa Bazardzanović; Fatima Iljazagić-Halilović
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.